Outcomes in patients with suspected lower extremity DVT from various sources
| Test accuracy results . | Consequences . | Results from published SR10 . | Results from treatment guideline11 . | Targeted search of outcomes studies12 . | Panel survey results . |
|---|---|---|---|---|---|
| TP | Mortality: all cause | NR | 2.0% (6 mo) | 6% (3 mo) | 8.8% (1 y) |
| Mortality: from DVT at 3-12 mo | 0.4% (PE mortality, 3 mo) | NR | 0% (3 mo) | 4.3% (1 y) | |
| Recurrence of DVT on anticoagulation at 3-12 mo | 3.8% (3 mo) | 1.3% (6 mo) | 4.6% (3 mo) | 5.6% (1 y) | |
| Development of PE | NR | 1.0% (6 mo) | 1.0% (3 mo) | 5.8% (1 y) | |
| Major bleeding | NR | 2.1% (6 mo) | 3.1% (3 mo) | 4.2% (1 y) | |
| Fatal major bleeding | NR | 0.2% (6 mo) | NR | NR | |
| Hemorrhagic stroke | NR | NR | NR | 2.0 (ICH; 1 y) | |
| FP | Mortality: all cause | NR | NR | NR | NR |
| Major bleeding | NR | 2.1% (6 mo) | 3.1% (3 mo) | 4.2% (1 y) | |
| Fatal major bleeding | NR | 0.2% (6 mo) | NR | NR | |
| TN | Mortality: from DVT at 3-12 mo | NR | NR | 0% | NR |
| FN | Mortality: all cause | NR | NR | NR | 18.4% (1 y) |
| Mortality: from DVT at 3-12 mo | NR | NR | NR | 10.5% (1 y) | |
| Recurrence of DVT on at 3-12 mo | NR | NR | NR | 11.0% (1 y) |
| Test accuracy results . | Consequences . | Results from published SR10 . | Results from treatment guideline11 . | Targeted search of outcomes studies12 . | Panel survey results . |
|---|---|---|---|---|---|
| TP | Mortality: all cause | NR | 2.0% (6 mo) | 6% (3 mo) | 8.8% (1 y) |
| Mortality: from DVT at 3-12 mo | 0.4% (PE mortality, 3 mo) | NR | 0% (3 mo) | 4.3% (1 y) | |
| Recurrence of DVT on anticoagulation at 3-12 mo | 3.8% (3 mo) | 1.3% (6 mo) | 4.6% (3 mo) | 5.6% (1 y) | |
| Development of PE | NR | 1.0% (6 mo) | 1.0% (3 mo) | 5.8% (1 y) | |
| Major bleeding | NR | 2.1% (6 mo) | 3.1% (3 mo) | 4.2% (1 y) | |
| Fatal major bleeding | NR | 0.2% (6 mo) | NR | NR | |
| Hemorrhagic stroke | NR | NR | NR | 2.0 (ICH; 1 y) | |
| FP | Mortality: all cause | NR | NR | NR | NR |
| Major bleeding | NR | 2.1% (6 mo) | 3.1% (3 mo) | 4.2% (1 y) | |
| Fatal major bleeding | NR | 0.2% (6 mo) | NR | NR | |
| TN | Mortality: from DVT at 3-12 mo | NR | NR | 0% | NR |
| FN | Mortality: all cause | NR | NR | NR | 18.4% (1 y) |
| Mortality: from DVT at 3-12 mo | NR | NR | NR | 10.5% (1 y) | |
| Recurrence of DVT on at 3-12 mo | NR | NR | NR | 11.0% (1 y) |
SR, systematic review.